IMAC Holdings, Inc. (BACK)
OTCMKTS
· Delayed Price · Currency is USD
0.0550
+0.0148 (36.82%)
Apr 23, 2025, 10:02 AM EDT
IMAC Holdings Revenue
In the year 2024, IMAC Holdings had annual revenue of $72.05K.
Revenue
72.05K
Revenue Growth
n/a
P/S Ratio
2.31
Revenue / Employee
4.80K
Employees
4
Market Cap
166.54K
Revenue Chart
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| SS Innovations International | 20.65M |
| Endo Inc. | 1.76B |
| Veradigm | 588.02M |
| Northwest Biotherapeutics | 1.38M |
| Elite Pharmaceuticals | 70.00M |
| Glass House Brands | 200.90M |
| BioStem Technologies | 301.83M |
| American Oncology Network | 1.76B |
IMAC Holdings News
- 2 months ago - Ignite Proteomics to Present Data on MHC-II as a Predictor of Pembrolizumab Response at NCCN Annual Conference - GlobeNewsWire
- 2 months ago - Ignite Proteomics Completes Acquisition of PLA Code 0249U for Its Advanced Proteomic Breast Cancer Assay - GlobeNewsWire
- 2 months ago - Ignite Proteomics Announces Publication of Study Demonstrating Superiority of Protein Activation Analysis in Predicting Breast Cancer Therapy Response - GlobeNewsWire
- 3 months ago - IMAC Holdings Introduces Ignite Proteomics: A New Standard for Matching Patients with the Right Cancer Therapies - GlobeNewsWire
- 5 months ago - IMAC Holdings receives notification of deficiency from Nasdaq related to delayed filing of quarterly report on Form 10-Q - GlobeNewsWire
- 5 months ago - IMAC Holdings Granted Extension by Nasdaq to Regain Compliance with Listing Rule 5250(c)(1) - GlobeNewsWire
- 7 months ago - IMAC Holdings Inc. Launches Subsidiary Ignite Proteomics and Announces Groundbreaking Precision Oncology Case Study Utilizing RPPA Technology - GlobeNewsWire
- 10 months ago - IMAC Holdings, Inc. Appoints Dr. Matthew Schwartz and Dr. Peter Beitsch to Board of Directors - GlobeNewsWire